September 2: MD Anderson Center for RNAs and ncRNAs and Penn Institute for RNA Innovation, UPenn

September 2: MD Anderson Center for RNAs and ncRNAs and Penn Institute for RNA Innovation, UPenn

by Nazende Nur Bayram · View the channel on PSI

Life & Natural Systems Biology PSBiology, life sciencesPSDMolecular biology
🎙 Nazende Nur Bayram 👥 2K 📅 September 28, 2026 ⏱ 59 min 👁 6 📄 original study 🧭 2026-09-28
Available in: English (current) Français

Keywords

extracellular vesiclesplant-derived vesiclescancer-associated fibroblastspresenilin 1immunotherapy

Summary

The seminar features a research talk by Dr. Nazende Nur Bayram from MD Anderson, who presents her work on harnessing plant-derived vesicles for targeted RNA delivery to treat ovarian cancer. She begins by introducing the challenges in RNA delivery, highlighting issues with current lipid nanoparticles and the potential of extracellular vesicles. She compares mammalian and plant-derived vesicles, noting advantages of the latter including scalability and low cost. Her research focuses on targeting cancer-associated fibroblasts (CAFs) in the tumor microenvironment, which are known to suppress T-cell infiltration. Through bioinformatics analysis, she identified presenilin 1 (PN1) as a key regulator in CAFs that promotes immunosuppression. Silencing PN1 via siRNA delivered in green tea-derived vesicles reduced immunosuppressive cytokines and enhanced T-cell migration. She developed a lab-on-a-chip model to demonstrate that PN1 loss increases T-cell infiltration. Further, she compared plant-derived vesicles (PDVs) with mammalian EVs, showing that green tea PDVs have higher loading efficiency, preferential tumor accumulation, and lower immunogenicity. In vivo experiments in ovarian cancer mouse models showed that green tea PDVs loaded with PN1 siRNA reduced tumor burden and remodeled the tumor microenvironment. A hybrid exosome-polymer nanoparticle formulation was also developed, showing enhanced delivery to CAFs and improved response to anti-CTLA4 immunotherapy. The talk concludes with future directions including identifying the components responsible for CAF uptake and optimizing loading methods.

218 words

Critical Evaluation

Value of the Information & Strength of the Argument

The talk presents a comprehensive and well-structured argument for using plant-derived vesicles as RNA delivery vehicles. The value lies in the innovative combination of bioinformatics screening, in vitro validation, and in vivo efficacy studies. The argumentation is logical, starting with a clear unmet need (improving RNA delivery), then justifying the choice of EVs, and progressively narrowing down to a specific plant source and target gene. The speaker provides quantitative data on vesicle characterization, loading efficiency, biodistribution, and therapeutic outcomes. However, the argumentation sometimes relies on visual data not fully described in the transcript, and the lack of precise molecular mechanisms (e.g., how vesicles preferentially target CAFs) is acknowledged as future work. Overall, the evidence supports the conclusions, but external validation and mechanistic details remain pending.

Scientific Rigor, Source Quality, Title Accuracy

The scientific rigor is moderate; the work is based on original experiments with appropriate controls, but the data are unpublished and no external citations are provided. The speaker references the NCI-60 panel and mentions a paper by Dr. Sara (likely a collaborator), but specific sources are not named. The title matches the content of the seminar, which includes this research talk and a second one not covered in the transcript. The title is accurate in representing the general topic, but the adequacy is slightly affected by the transcript only containing the first talk. The lack of peer-reviewed references diminishes the overall reliability, though the methodological details suggest careful experimental design.

250 words

Title / Content Match

The title matches the seminar content, which consists of two research talks. The transcript covers only the first talk, but the theme of RNA innovation aligns well with the presented work.

Quality & Reliability

8/10

Presentation of unpublished research with clear experimental data, but lacking peer review and external validation. The scientific reasoning is solid, though the transcription contains many errors that require interpretation.

Key Moments

Markers derived by PSI from the transcript: the creator did not define chapters.

Contribution & Novelties

The talk introduces a novel approach of using plant-derived vesicles (specifically green tea) for targeted RNA delivery to cancer-associated fibroblasts, with the goal of reversing immunosuppression in ovarian cancer. The identification of PN1 as a key regulator and the development of a hybrid exosome-polymer nanoparticle are notable contributions. The comparative analysis between plant and mammalian EVs provides new insights into their differential safety and efficacy profiles.

Pour aller plus loin :

102 words

Radar Profile

The radar profile shows high scores in quantity of information, technical level, and global reliability, with slightly lower quality of information due to the unpublished nature and lack of external references. This indicates a technically rich presentation with significant data, but requiring further validation.

Reliability 7/10